167 related articles for article (PubMed ID: 26265188)
21. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
[TBL] [Abstract][Full Text] [Related]
22. Eudragit: a technology evaluation.
Thakral S; Thakral NK; Majumdar DK
Expert Opin Drug Deliv; 2013 Jan; 10(1):131-49. PubMed ID: 23102011
[TBL] [Abstract][Full Text] [Related]
23. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
[TBL] [Abstract][Full Text] [Related]
24. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
Bodmeier R; Guo X; Sarabia RE; Skultety PF
Pharm Res; 1996 Jan; 13(1):52-6. PubMed ID: 8668678
[TBL] [Abstract][Full Text] [Related]
25. Applicability of near-infrared spectroscopy in the monitoring of film coating and curing process of the prolonged release coated pellets.
Korasa K; Hudovornik G; Vrečer F
Eur J Pharm Sci; 2016 Oct; 93():484-92. PubMed ID: 27562707
[TBL] [Abstract][Full Text] [Related]
26. Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
Chen K; Chang HHR; Shalviri A; Li J; Lugtu-Pe JA; Kane A; Wu XY
Eur J Pharm Biopharm; 2017 Nov; 120():116-125. PubMed ID: 28887098
[TBL] [Abstract][Full Text] [Related]
27. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
Dashevsky A; Kolter K; Bodmeier R
Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
[TBL] [Abstract][Full Text] [Related]
28. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets.
Cuppok Y; Muschert S; Marucci M; Hjaertstam J; Siepmann F; Axelsson A; Siepmann J
Int J Pharm; 2011 May; 409(1-2):30-7. PubMed ID: 21354465
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
[TBL] [Abstract][Full Text] [Related]
30. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
31. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers.
Moustafine RI; Bukhovets AV; Sitenkov AY; Kemenova VA; Rombaut P; Van den Mooter G
Mol Pharm; 2013 Jul; 10(7):2630-41. PubMed ID: 23777284
[TBL] [Abstract][Full Text] [Related]
32. Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55.
Zhang X; Wang Y; Wang J; Wang Y; Li S
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1261-3. PubMed ID: 17666856
[TBL] [Abstract][Full Text] [Related]
33. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
34. Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.
Moustafine RI; Zaharov IM; Kemenova VA
Eur J Pharm Biopharm; 2006 May; 63(1):26-36. PubMed ID: 16380241
[TBL] [Abstract][Full Text] [Related]
35. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery.
Semdé R; Amighi K; Devleeschouwer MJ; Moës AJ
Int J Pharm; 2000 Mar; 197(1-2):181-92. PubMed ID: 10704805
[TBL] [Abstract][Full Text] [Related]
36. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
[TBL] [Abstract][Full Text] [Related]
37. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
38. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
39. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation.
Obeidat WM; Abu Znait AH; Sallam AS
Drug Dev Ind Pharm; 2008 Jun; 34(6):650-60. PubMed ID: 18568916
[TBL] [Abstract][Full Text] [Related]
40. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
